Terazosin
- Product NDC
- 71610-510
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Terazosin Hydrochloride
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- ANDA075317
- Marketing category
- ANDA
- Substance
- TERAZOSIN HYDROCHLORIDE
- Current FDA listing
- Yes
Packages
| Package NDC | Description | Marketing start | Marketing end | Sample | Status |
|---|
| 71610-510-30 | 30 CAPSULE in 1 BOTTLE (71610-510-30) | 2020-12-29 | | No | Historical |
| 71610-510-53 | 60 CAPSULE in 1 BOTTLE (71610-510-53) | 2020-12-29 | | No | Historical |
| 71610-510-60 | 90 CAPSULE in 1 BOTTLE (71610-510-60) | 2020-12-29 | | No | Historical |
| 71610-510-70 | 120 CAPSULE in 1 BOTTLE (71610-510-70) | 2020-12-29 | | No | Historical |
| 71610-510-80 | 180 CAPSULE in 1 BOTTLE (71610-510-80) | 2020-12-29 | | No | Historical |
| 71610-510-92 | 270 CAPSULE in 1 BOTTLE (71610-510-92) | 2020-12-29 | | No | Historical |
| 71610-510-94 | 360 CAPSULE in 1 BOTTLE (71610-510-94) | 2020-12-29 | | No | Historical |